CAH Insider Sale Filed: 41,575 Shares to be Sold on NYSE via Merrill Lynch

Rhea-AI Filing Summary

Form 144 notice from Cardinal Health, Inc. (CAH) discloses a proposed sale of 41,575 common shares through Merrill Lynch on the NYSE with an aggregate market value reported as $6,186,923 and an approximate sale date of 08/19/2025. The securities being offered were acquired by the selling person through vesting events: performance stock vesting (30,077 shares on 08/15/2025 and 3,692 shares on 06/30/2025) and restricted stock vesting (7,806 shares on 08/15/2025). The filer certifies no undisclosed material adverse information and indicates no sales by the person in the past three months.

Positive

• Full compliance disclosure with Rule 144 format including broker, exchange, share count, and aggregate market value
• Acquisition details provided with dates and nature of vesting for all securities to be sold
• No sales in prior three months reported for the person whose account will be sold

Negative

• Proposed sale size disclosed is 41,575 shares with an aggregate market value of $6,186,923 which could add selling supply on the stated date
• Timing concentrated with the majority of shares acquired and vesting in mid-August 2025 prior to the approximate sale date

Insights

Securities Analyst

TL;DR: Insider plans to sell 41,575 shares valued at $6.19M; disclosure satisfies Rule 144 reporting requirements.

The filing provides clear, itemized acquisition dates and vesting types for all 41,575 shares to be sold and names the executing broker and exchange. For investors, this is routine insider liquidity rather than a corporate operating disclosure. The aggregate value and timing are explicit, enabling market participants to anticipate potential supply on the NYSE around the stated sale date.

Corporate Governance Expert

TL;DR: Form 144 filing appears complete for regulatory purposes and includes signer representations required by the form.

The document states the required representation that the seller is not aware of undisclosed material adverse information and lists the vesting origins of the securities. The absence of reported sales in the prior three months is noted. The filing aligns with routine insider disclosure practices under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 8890 Lyra Dr. 5th Floor Columbus OH 43240	41575	6186923.00	238793647	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Performance Stock Vesting	CARDINAL HEALTH INC			30077	08/15/2025	NA
Common	08/15/2025	Restricted Stock Vesting	CARDINAL HEALTH INC			7806	08/15/2025	NA
Common	06/30/2025	Performance Stock Vesting	CARDINAL HEALTH INC			3692	06/30/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Cardinal Health's (CAH) Form 144 disclose?

The filing discloses a proposed sale of 41,575 common shares on the NYSE via Merrill Lynch with an aggregate market value of $6,186,923 and an approximate sale date of 08/19/2025.

How were the shares acquired for the CAH Form 144 sale?

Shares were acquired through vesting events: performance stock vesting on 08/15/2025 (30,077 shares) and 06/30/2025 (3,692 shares), and restricted stock vesting on 08/15/2025 (7,806 shares).

Who is the broker and where will CAH shares be sold?

The broker is listed as Merrill Lynch, 8890 Lyra Dr., 5th Floor, Columbus OH 43240 and the securities exchange is the NYSE.

Did the filer report any sales in the past three months?

The filing states Nothing to Report under securities sold during the past three months for the person whose account is to be sold.

What certification does the seller make in the Form 144?

The signer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed, and the form includes the standard signature warning about intentional misstatements.